Post-Poliomyélitis Syndrom Clinical Trial
Official title:
Treatment of Post-poliomyelitis Syndrome by Intravenous Immunoglobulin: a Retrospective Study of Efficacy on Clinical and Isokinetic Criteria
Our study evaluates the efficacy of IGIV treatment in PPS on clinical (walking and pain) and isokinetic (muscle strength) criteria, on patients with PS at Montpellier's Hospital
Patients are admitted to a multidisciplinary consultation (neurologist, PMK) to validate the
indication of treatment with IGIV. Realization of a pre-therapeutic evaluation in the
department of MPR on the criteria of judgment, then the patient is admitted in a service of
neurology to benefit from the cure of IGIV. The patient is then re-admitted to a PMR service
for post-treatment evaluation.
Collection of data retrospectively.
;